Related Experiment Video
Updated: Feb 17, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia
Mouna Ouchari1, Kshitij Srivastava1, Houda Romdhane2
1Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland.
In Tunisia, weak D Type 4.0 is the most common weak D phenotype, found in nearly 90% of cases. Researchers recommend RhD-positive (D+) transfusions for these patients due to a lack of adverse events.
Area of Science:
- Immunogenetics
- Blood group serology
- Population genetics
Background:
- The RHD gene is highly polymorphic, with over 460 alleles, making it the most complex blood group system.
- Tunisia exhibits a high prevalence of weak D Type 4.0 alleles, affecting 1 in 105 RH haplotypes.
Purpose of the Study:
- To investigate the prevalence and characteristics of weak D phenotypes in the Tunisian population.
- To establish a transfusion strategy for individuals with weak D Type 4.0 in Tunisia.
Main Methods:
- Screening of 13,431 Tunisian blood donations for serologic weak D phenotype.
- Sequencing of the RHD coding sequence and introns.
- RHCE gene analysis to determine RH haplotypes.
Main Results:
- A weak D phenotype was identified in 0.50% (67/13,431) of donors.
- Weak D Type 4 alleles accounted for nearly 90% of weak D phenotypes, with Type 4.0 being the most frequent (88% of weak D Type 4).
- Specific RHCE alleles were commonly associated with different RHD variants, such as RHCE*ceVS.04.01 with weak D Type 4.0.
Conclusions:
- Weak D Type 4.0 is the predominant weak D allele in Tunisia.
- No novel RHD alleles were identified.
- Based on established haplotypes and the absence of adverse clinical events, RhD-positive (D+) transfusions are recommended for patients with weak D Type 4.0 in Tunisia.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
07:27A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting
Published on: May 16, 2013
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Rh Blood Group
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
The ABO Blood Group
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...